The generation and properties of human M2-like macrophages: Potential candidates for CNS repair?

Cellular Therapy and Transplantation

Volumn 2, Issue 6, 2010, Pages

  Chernykh, Elena R ^a   Shevela, Ekaterina Ya ^a   Sakhno, Ludmila V ^a   Tikhonova, Marina A ^a   Petrovsky, Yaroslav L ^a   Ostanin, Alexander A ^a  

^a INSTITUTE OF CLINICAL IMMUNOLOGY   (Russian Federation)

Author keywords

Chemokines; CNS repair; Cytokines; Growth factors; Macrophage polarization

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CD86 ANTIGEN; COLONY STIMULATING FACTOR 1; EPIDERMAL GROWTH FACTOR; ERYTHROPOIETIN; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ANTIGEN EXPRESSION; ARTICLE; CELL COUNT; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; M2 LIKE MACROPHAGE; MACROPHAGE; MONOCYTE; NERVE REGENERATION; NERVOUS SYSTEM INJURY; NEUROPROTECTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; TISSUE REPAIR;

EID: 84856827114     PISSN: 1867416X     EISSN: 18668836     Source Type: Journal    
DOI: 10.3205/ctt-2010-en-000080.01     Document Type: Article

References (38)

1. Abe, K. Effects of basic fbroblast growth factor on central nervous system functions. Pharmacol Res. 2001;43:307-302.
2. Apel PJ, Ma J, Callahan M, Northam CN, Alton TB, Sonntag WE, Li Z. Effect of locally delivered IGF-1 on nerve regeneration during aging: an experimental study in rats. Muscle Nerve. 2009 Oct. 2. doi: 10.1002/mus.21485.
3. Bomstein Y, Marder JB, Vitner K, Smirnov I, Lisaey G, Butovs-ky O, Fulga V, Yoles E. Features of skin-coincubated macrophages that promote recovery from spinal cord injury. J Neuroimmunol. 2003;142:10-16. doi: 10.1016/S0165-5728(03)00260-1.
4. Carro E, Trejo JL, Núñez, A, Torres-Aleman I. Brain repair and neuroprotection by serum insulin-like growth factor-I. Mol Neuro-biol. 2003;27:153-162. doi: 10.1385/MN:27:2:153.
5. Correale J, Villa A. The neuroprotective role of infammation in nervous system injuries. J Neurol. 2004;251:1304-1316. doi: 10.1007/s00415-004-0649-z.
6. Donnelly DJ, Popovich PG. Infammation and its role in neuro-protection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol. 2008;209:378-388. doi: 10.1016/j.expneu-rol.2007.06.009.
7. Elkabes S, Dicicco-Bloom EM, Black IB. Brain microglia/ma-crophages express neurotrophins that selectively regulate microglial proliferation and function. J Neurosci. 1996;16:2508-2521. pmid: 8786427.
8. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Hen-son PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinfammatory cytokine production through autocrine/parac-rine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest. 1998;101:890-898. doi: 10.1172/JCI1112.
9. Fitch MT, Silver J. Activated macrophages and the blood-brain barrier: infammation after CNS injury leads to increases in putative inhibitory molecules. Exp Neurol. 1997;148:587-603. doi: 10.1006/exnr.1997.6701.
10. Gordon, S. Alternative activation of macrophages. Nat Rev Immunol. 2003;3:23-35. doi:10.1038/nri978.
11. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 2005;5:953-964. doi: 10.1038/nri1733.
12. Hohlfeld R, Kerschensteiner M, Meinl E. Dual role of infamma-tion in CNS disease. Neurology. 2007;68(3):58-63. pmid: 17548571.
13. Kerschensteiner M, Gallmeier E, Behrens L, Leal VV, Misgeld T, Klinkert WEF, Kolbeck R, Hoppe E, Oropeza-Wekerle R-L, Bartke L, Stadelmann C, Lassmann H, Wekerle H, Hohlfeld R. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in infammatory brain lesions: a neu-roprotective role of infammation? J Exp Med. 1999;189:865-870.
14. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG. Identifcation of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J. Neurosci. 2009;29:13435-13444. doi: 10.1523/JNEUROSCI.3257-09.2009.
15. King C.E, Rodger J, Bartlett C, Esmaili T, Dunlop SA, Beazley LD. Erythropoietin is both neuroprotective and neuroregenerative following optic nerve transaction. Exp Neurol. 2007;205:48-55.
16. Knoller N, Auerbach G, Fulga V, Zelig G, Attias J, Bakimer R, Marder JB, Yoles E, Belkin M, Schwartz M, Hadani M. Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: phase I study results. J Neurosurg. 2005;3:173-181.
17. Leskovar A, Moriarty LJ, Turek JJ, Schoenlein IA, Borgens RB. The macrophage in acute neural injury: changes in cell numbers over time and levels of cytokine production in mammalian central and peripheral nervous systems. J Exp Biol. 2000;203:1783-1795.
18. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004;25:677-686. doi:10.1016/j. it.2004.09.015.
19. McPhail LT, Stirling DP, Tetzlaff W, Kwiecien JM, Ramer MS. The contribution of activated phagocytes and myelin degeneration to axonal retraction/dieback following spinal cord injury. Eur J Neu-rosci. 2004;20:1984-1994. doi: 10.1111/j.1460-9568.2004.03662.x.
20. Mosser DM. The many faces of macrophage activation. J Leukocyte Biol. 2003;73:209-212.
21. Pelegrin P, Surprenant A. Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1beta release through pyrophos-phates. EMBO J. 2009;28:2114-2127. doi: 10.1038/emboj.2009.163.
22. Plesner A, Greenbaumb CJ, Lernmarka A. Low serum conditions for in vitro generation of human macrophages with macrophage colony stimulating factor. J Immunol Meth. 2001;249:53-61.
23. Prewitt CM, Niesman IR, Kane CJ, Houle JD. Activated ma-crophage/microglial cells can promote the regeneration of sensory axons into the injured spinal cord. Exp Neurol. 1997;148:433-443. doi:10.1006/exnr.1997.6694.
24. Rabchevsky AG, Streit WJ. Grafting of cultured microglial cells into the lesioned spinal cord of adult rats enhances neurite out growth. J Neurosci Res. 1997;47:34-48 doi: 10.1002/(SICI)1097- 4547(19970101)47:1<34::AID-JNR4>3.0.CO;2-G
25. Rapalino O, Lazarov-Spiegler O, Agranov E, Velan GJ, Yoles E, Fraidakis M, Solomon A, Gepstein R, Katz A, Belkin M, Hadani M, Schwartz M. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat Med. 1998;4:814-821. pmid: 9662373.
26. Schneider A, Kruger C, Steigleder T, Weber D, Pitzer C, Laage R, Aronowski J, Maurer MH, Gassler N, Mier W, Hasselblatt M, Kollmar R, Schwab S, Sommer C, Bach A, Kuhn HG, Schabitz WR. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest. 2005;115:2083-2098. doi:10.1172/JCI23559.
27. Schwartz M, Lazarov-Spiegler O, Rapalino O, Agranov I, Velan G, Hadani M. Potential repair of rat spinal cord injuries using stimulated homologous macrophages. Neurosurgery. 1999;44:1041-1045. pmid: 10232537.
28. Shechter R, London A, Varol C, Raposo C, Cusimano M, Yo-vel G, Rolls A, Mack M, Pluchino S, Martino G, Jung S, Schwartz M. Infltrating blood-derived macrophages are vital cells playing an anti-infammatory role in recovery from spinal cord injury in mice. PLoS Medicine. 2009;6:1-16.
29. Spate CK, Krampe H, Ehrenreich H. Recombinant human ery-thropoietin: novel strategies for neuroprotective/neuroregenerative treatment of multiple sclerosis. Therapeutic Advances in Neurological Disorders. 2008;1:193-206.
30. Stoll G, Jander S, Schroeter M. Detrimental and benefcial effects of injury-induced infammation and cytokine expression in the nervous system. Adv Exp Med Biol. 2002;513:87-113. pmid: 12575818.
31. Storkebaum E, Carmeliet P. VEGF: a critical player in neurode-generation. J Clin Invest. 2004;113:14-18. doi: 10.1172/JCI20682.
32. Stout RD, Jiang C, Matta B, Tietzel I, Watkins SK, Suttles J. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental infuences. J Immunol. 2005;175:342-349.
33. Turrin NP, Rivest S. Molecular and cellular immune mediators of neuroprotection. Molecular Neurobiology. 2006;34:221-242. doi: 10.1385/MN:34:3:221.
34. Verreck FA, de Boer T, Langenberg DM, Hoeve MA, Kramer M, Vaisberg E, Kastelein R, Kolk A, de Waal-Malefyt R, Ottenhoff TH. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to mycobacte-ria. Proc. Natl. Acad. Sci. USA. 2004;101:4560-4565. doi: 10.1073/ pnas.0400983101.
35. Verreck FA, de Boer T, Langenberg DM, van der Zanden L, Ottenhoff TH. Phenotypic and functional profling of human pro-infammatory type-1 and anti-infammatory type-2 macrophages in response to microbial antigens and IFN- - and CD40L-mediated costimulation. J. Leukocyte Biol. 2006;79:285-293. doi:10.1189/ jlb.0105015.
36. Wing R, Wong C, Guillaud L. The role of epidermal growth factor and its receptors in mammalian CNS. Cytokines & Growth factors. 2004;15:147-156.
37. Yin Y, Cui Q, Li Y, Irwin N, Fischer D, Harvey AR, Benowitz LI. Macrophage-derived factors stimulate optic nerve regeneration. J Neurosci. 2003;23:2284-2293.
38. Zhang ZG, Zhang L, Jiang Q, Zhang R, Davies K, Powers C, van Bruggen N, Chopp M. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest. 2000;106:829-838.